SCHEMBL7533532

SCHEMBL7533532

COc1cccc(OC2CN(C3CCC(c4cc5ccccc5[nH]4)CC3)C2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.45
SLC6A4 P31645 1/20 0.45
SLC6A3 Q01959 1/20 0.45
HTR1A P08908 3/20 0.39
ADRA1D P25100 2/20 0.39
ADRA1A P35348 2/20 0.39
ADRA1B P35368 2/20 0.39
PDE9A O76083 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
DRD2 P14416 1/20 0.37
DRD3 P35462 1/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
LMNA P02545 1/20 0.37
TSHR P16473 1/20 0.37
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
MCOLN3 Q8TDD5 1/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7533925 1.00 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3HTR1AADRA1D
SCHEMBL7533530 1.00 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3HTR1AADRA1D
SCHEMBL7534575 0.85 SLC6A2 (0.42) SLC6A2SLC6A4SLC6A3HTR1AADRA1D
SCHEMBL7535384 0.85 SLC6A2 (0.42) SLC6A2SLC6A4SLC6A3HTR1AADRA1D
SCHEMBL26619764 0.77 SLC6A2 (0.54) SLC6A2SLC6A4SLC6A3HTR1AADRA1D
SCHEMBL24317818 0.74 SLC6A2 (0.50) SLC6A2SLC6A4SLC6A3HTR1AADRA1D
SCHEMBL27010171 0.73 SLC6A2 (0.49) SLC6A2SLC6A4SLC6A3HTR1AADRA1D
SCHEMBL73543 0.72 AOC3 (0.47) SLC6A4SLC6A3KDM4EALDH1A1NPC1
SCHEMBL7535549 0.70 HTR1A (0.61) SLC6A2SLC6A4SLC6A3HTR1AHTR2A
SCHEMBL7534723 0.70 HTR1A (0.61) SLC6A2SLC6A4SLC6A3HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1228065-A1 (INDOL-3-YL)-CYCLOALKYL]-3-SUBSTITUTED AZETIDINES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS Wyeth (US) 2002-08-07 EP claimed
US-6245799-B1 PSYCHOLOGICAL DISORDERS; ANTIDEPRESSANTS; ANXIOLYTIC AGENTS AMERICAN HOME PRODUCTS CORP 2001-06-12 US claimed
WO-2001034598-A1 [(INDOL-3-YL)-CYCLOALKYL]-3-SUBSTITUTED AZETIDINES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS WYETH (US) 2001-05-17 WO claimed
EP-1228065-A1 (INDOL-3-YL)-CYCLOALKYL]-3-SUBSTITUTED AZETIDINES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS Wyeth (US) 2002-08-07 EP disclosed
US-6245799-B1 PSYCHOLOGICAL DISORDERS; ANTIDEPRESSANTS; ANXIOLYTIC AGENTS AMERICAN HOME PRODUCTS CORP 2001-06-12 US disclosed
WO-2001034598-A1 [(INDOL-3-YL)-CYCLOALKYL]-3-SUBSTITUTED AZETIDINES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS WYETH (US) 2001-05-17 WO disclosed